Nicola Beltraminelli | VP, Chief Development Officer
INNATE PHARMA

Dr. Nicola Beltraminelli joined Innate Pharma as Vice President and Chief Development Officer in January 2022.  Dr. Beltraminelli brings more than 20 years of biotech experience to the role, and specifically in the development of biologic products from early discovery to GMP manufacture. 
Most recently, Dr. Beltraminelli served as Chief Technical Officer at Lysogene, where he led the CMC activities for two late-stage assets. Prior to Lysogene, he held senior level positions at HiFiBiO Therapeutics and BliNK Biomedical SAS.  At HiFiBiO, Dr. Beltraminelli led the R&D activities of the company’s French site, as well as its global CMC efforts, bringing several projects to the clinic.
Dr. Beltraminelli holds a PhD in Molecular Biology from the University of Lausanne, Switzerland, and currently serves as a Board member of MabDesign